Abiopharma

🔍 Kumar Dinesh M. (Executive)

Company: Astrana Health, Inc. (ASTH)

Report Date: 2026-01-01

Detailed Transactions and Holdings:

• Sold 5,102 shares of Common Stock at $24.81 per share (Direct)
  Date: 2026-01-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 212,791.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on January 1, 2026.
• F2: Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.
• F3: Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.